The novel second-generation triterpenoid SCY-247 maintains in vitro and in vivo activity against resistant Candida glabrata.
Saved in:
| Title: | The novel second-generation triterpenoid SCY-247 maintains in vitro and in vivo activity against resistant Candida glabrata. |
|---|---|
| Authors: | Wiederhold NP; University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Najvar LK; University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Jaramillo R; University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Olivo M; University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Patterson HP; University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Patterson TF; University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2026 Apr; Vol. 70 (4), pp. e0162525. Date of Electronic Publication: 2026 Feb 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1098-6596 |
|---|---|
| DOI: | 10.1128/aac.01625-25 |
